Advertisement

Index by Author

December 1996; 45 (12)
  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z

A

  1. Abate, N

    • Relationship of generalized and regional adiposity to insulin sensitivity in men with NIDDM. Diabetes December 1996 45:1684-1693; doi:10.2337/diabetes.45.12.1684

  2. Adams-Huet, B

    • Relationship of generalized and regional adiposity to insulin sensitivity in men with NIDDM. Diabetes December 1996 45:1684-1693; doi:10.2337/diabetes.45.12.1684

  3. Akerblom, H K

    • Disease-associated antibodies in offspring of mothers with IDDM. Diabetes December 1996 45:1706-1710; doi:10.2337/diabetes.45.12.1706

  4. Anderson, J H

    • Immunologic effects of insulin lispro [Lys (B28), Pro (B29) human insulin] in IDDM and NIDDM patients previously treated with insulin. Diabetes December 1996 45:1750-1754; doi:10.2337/diabetes.45.12.1750

  5. Andreu, E

    • Diminished fraction of blockable ATP-sensitive K+ channels in islets transplanted into diabetic mice. Diabetes December 1996 45:1755-1760; doi:10.2337/diabetes.45.12.1755

  6. Angelov, I

    • Increased hexosamine availability similarly impairs the action of insulin and IGF-1 on glucose disposal. Diabetes December 1996 45:1734-1743; doi:10.2337/diabetes.45.12.1734

B

  1. Barzilai, N

    • Increased hexosamine availability similarly impairs the action of insulin and IGF-1 on glucose disposal. Diabetes December 1996 45:1734-1743; doi:10.2337/diabetes.45.12.1734

  2. Bhattacharjee, A

    • Abnormally expressed low-voltage-activated calcium channels in beta-cells from NOD mice and a related clonal cell line. Diabetes December 1996 45:1678-1683; doi:10.2337/diabetes.45.12.1678

  3. Bingley, P J

    • Interactions of age, islet cell antibodies, insulin autoantibodies, and first-phase insulin response in predicting risk of progression to IDDM in ICA+ relatives: the ICARUS data set. Islet Cell Antibody Register Users Study. Diabetes December 1996 45:1720-1728; doi:10.2337/diabetes.45.12.1720

  4. Birkett, M A

    • Immunologic effects of insulin lispro [Lys (B28), Pro (B29) human insulin] in IDDM and NIDDM patients previously treated with insulin. Diabetes December 1996 45:1750-1754; doi:10.2337/diabetes.45.12.1750

  5. Blum, J

    • Major histocompatibility complex class II molecules function as a template for the processing of a partially processed insulin peptide into a T-cell epitope. Diabetes December 1996 45:1711-1719; doi:10.2337/diabetes.45.12.1711

  6. Brown, K S

    • Heterologous expression and characterization of rat liver glucokinase regulatory protein. Diabetes December 1996 45:1670-1677; doi:10.2337/diabetes.45.12.1670

  7. Butler, P C

    • Mechanisms of sulfonylurea's stimulation of insulin secretion in vivo: selective amplification of insulin secretory burst mass. Diabetes December 1996 45:1792-1797; doi:10.2337/diabetes.45.12.1792

C

  1. Chen, W

    • Increased hexosamine availability similarly impairs the action of insulin and IGF-1 on glucose disposal. Diabetes December 1996 45:1734-1743; doi:10.2337/diabetes.45.12.1734

  2. Cherrington, A D

    • In the absence of counterregulatory hormones, the increase in hepatic glucose production during insulin-induced hypoglycemia in the dog is initiated in the liver rather than the brain. Diabetes December 1996 45:1805-1813; doi:10.2337/diabetes.45.12.1805

  3. Cohen, P

    • Increased hexosamine availability similarly impairs the action of insulin and IGF-1 on glucose disposal. Diabetes December 1996 45:1734-1743; doi:10.2337/diabetes.45.12.1734

  4. Colovai, A I

    • Tissue-specific self-peptides bound by major histocompatibility complex class I molecules of a human pancreatic beta-cell line. Diabetes December 1996 45:1761-1765; doi:10.2337/diabetes.45.12.1761

  5. Connolly, C C

    • In the absence of counterregulatory hormones, the increase in hepatic glucose production during insulin-induced hypoglycemia in the dog is initiated in the liver rather than the brain. Diabetes December 1996 45:1805-1813; doi:10.2337/diabetes.45.12.1805

  6. Corbett, J A

    • Dual functional effects of interleukin-1beta on purine nucleotides and insulin secretion in rat islets and INS-1 cells. Diabetes December 1996 45:1783-1791; doi:10.2337/diabetes.45.12.1783

D

  1. Davidoff, A J

    • Troglitazone attenuates high-glucose-induced abnormalities in relaxation and intracellular calcium in rat ventricular myocytes. Diabetes December 1996 45:1822-1825; doi:10.2337/diabetes.45.12.1822

  2. Delovitch, T L

    • Major histocompatibility complex class II molecules function as a template for the processing of a partially processed insulin peptide into a T-cell epitope. Diabetes December 1996 45:1711-1719; doi:10.2337/diabetes.45.12.1711

  3. De Paepe, M

    • Long-term metabolic control by rat islet grafts depends on the composition of the implant. Diabetes December 1996 45:1814-1821; doi:10.2337/diabetes.45.12.1814

  4. Dominguez, L J

    • Troglitazone attenuates high-glucose-induced abnormalities in relaxation and intracellular calcium in rat ventricular myocytes. Diabetes December 1996 45:1822-1825; doi:10.2337/diabetes.45.12.1822

E

  1. Egan, J J

    • Chronic dosing with aminoguanidine and novel advanced glycosylation end product-formation inhibitors ameliorates cross-linking of tail tendon collagen in STZ-induced diabetic rats. Diabetes December 1996 45:1694-1700; doi:10.2337/diabetes.45.12.1694

  2. Estrada, D E

    • Stimulation of glucose uptake by the natural coenzyme alpha-lipoic acid/thioctic acid: participation of elements of the insulin signaling pathway. Diabetes December 1996 45:1798-1804; doi:10.2337/diabetes.45.12.1798

  3. Ewart, H S

    • Stimulation of glucose uptake by the natural coenzyme alpha-lipoic acid/thioctic acid: participation of elements of the insulin signaling pathway. Diabetes December 1996 45:1798-1804; doi:10.2337/diabetes.45.12.1798

F

  1. Fineberg, N S

    • Immunologic effects of insulin lispro [Lys (B28), Pro (B29) human insulin] in IDDM and NIDDM patients previously treated with insulin. Diabetes December 1996 45:1750-1754; doi:10.2337/diabetes.45.12.1750

  2. Fineberg, S E

    • Immunologic effects of insulin lispro [Lys (B28), Pro (B29) human insulin] in IDDM and NIDDM patients previously treated with insulin. Diabetes December 1996 45:1750-1754; doi:10.2337/diabetes.45.12.1750

  3. Forquet, F

    • Major histocompatibility complex class II molecules function as a template for the processing of a partially processed insulin peptide into a T-cell epitope. Diabetes December 1996 45:1711-1719; doi:10.2337/diabetes.45.12.1711

  4. Fu, J

    • Abnormally expressed low-voltage-activated calcium channels in beta-cells from NOD mice and a related clonal cell line. Diabetes December 1996 45:1678-1683; doi:10.2337/diabetes.45.12.1678

G

  1. Garg, A

    • Relationship of generalized and regional adiposity to insulin sensitivity in men with NIDDM. Diabetes December 1996 45:1684-1693; doi:10.2337/diabetes.45.12.1684

  2. Gibson, R G

    • Immunologic effects of insulin lispro [Lys (B28), Pro (B29) human insulin] in IDDM and NIDDM patients previously treated with insulin. Diabetes December 1996 45:1750-1754; doi:10.2337/diabetes.45.12.1750

  3. Gorus, F

    • Long-term metabolic control by rat islet grafts depends on the composition of the implant. Diabetes December 1996 45:1814-1821; doi:10.2337/diabetes.45.12.1814

  4. Grundy, S M

    • Relationship of generalized and regional adiposity to insulin sensitivity in men with NIDDM. Diabetes December 1996 45:1684-1693; doi:10.2337/diabetes.45.12.1684

H

  1. Hamaguchi, K

    • PDX-1 induces insulin and glucokinase gene expressions in alphaTC1 clone 6 cells in the presence of betacellulin. Diabetes December 1996 45:1826-1831; doi:10.2337/diabetes.45.12.1826

  2. Hanafusa, T

    • PDX-1 induces insulin and glucokinase gene expressions in alphaTC1 clone 6 cells in the presence of betacellulin. Diabetes December 1996 45:1826-1831; doi:10.2337/diabetes.45.12.1826

  3. Harris, P E

    • Tissue-specific self-peptides bound by major histocompatibility complex class I molecules of a human pancreatic beta-cell line. Diabetes December 1996 45:1761-1765; doi:10.2337/diabetes.45.12.1761

  4. Hastings, J R

    • In the absence of counterregulatory hormones, the increase in hepatic glucose production during insulin-induced hypoglycemia in the dog is initiated in the liver rather than the brain. Diabetes December 1996 45:1805-1813; doi:10.2337/diabetes.45.12.1805

  5. Hawkins, M

    • Increased hexosamine availability similarly impairs the action of insulin and IGF-1 on glucose disposal. Diabetes December 1996 45:1734-1743; doi:10.2337/diabetes.45.12.1734

  6. Hayami, T

    • Identification of two missense mutations in the GIP receptor gene: a functional study and association analysis with NIDDM: no evidence of association with Japanese NIDDM subjects. Diabetes December 1996 45:1701-1705; doi:10.2337/diabetes.45.12.1701

  7. Hill, C

    • Glomerular hyperfiltration in the prediction of nephropathy in IDDM: a 10-year follow-up study. Diabetes December 1996 45:1729-1733; doi:10.2337/diabetes.45.12.1729

  8. Hufferd, S

    • Immunologic effects of insulin lispro [Lys (B28), Pro (B29) human insulin] in IDDM and NIDDM patients previously treated with insulin. Diabetes December 1996 45:1750-1754; doi:10.2337/diabetes.45.12.1750

  9. Hu, M

    • Increased hexosamine availability similarly impairs the action of insulin and IGF-1 on glucose disposal. Diabetes December 1996 45:1734-1743; doi:10.2337/diabetes.45.12.1734

I

  1. Ihara, Y

    • Identification of two missense mutations in the GIP receptor gene: a functional study and association analysis with NIDDM: no evidence of association with Japanese NIDDM subjects. Diabetes December 1996 45:1701-1705; doi:10.2337/diabetes.45.12.1701

  2. Ilonen, J

    • Disease-associated antibodies in offspring of mothers with IDDM. Diabetes December 1996 45:1706-1710; doi:10.2337/diabetes.45.12.1706

J

  1. Jaraquemada, D

    • Tissue-specific self-peptides bound by major histocompatibility complex class I molecules of a human pancreatic beta-cell line. Diabetes December 1996 45:1761-1765; doi:10.2337/diabetes.45.12.1761

  2. Jones, S L

    • Glomerular hyperfiltration in the prediction of nephropathy in IDDM: a 10-year follow-up study. Diabetes December 1996 45:1729-1733; doi:10.2337/diabetes.45.12.1729

K

  1. Kagimoto, S

    • Identification of two missense mutations in the GIP receptor gene: a functional study and association analysis with NIDDM: no evidence of association with Japanese NIDDM subjects. Diabetes December 1996 45:1701-1705; doi:10.2337/diabetes.45.12.1701

  2. Kajimoto, Y

    • PDX-1 induces insulin and glucokinase gene expressions in alphaTC1 clone 6 cells in the presence of betacellulin. Diabetes December 1996 45:1826-1831; doi:10.2337/diabetes.45.12.1826

  3. Kalinowski, S S

    • Heterologous expression and characterization of rat liver glucokinase regulatory protein. Diabetes December 1996 45:1670-1677; doi:10.2337/diabetes.45.12.1670

  4. Kawamori, R

    • PDX-1 induces insulin and glucokinase gene expressions in alphaTC1 clone 6 cells in the presence of betacellulin. Diabetes December 1996 45:1826-1831; doi:10.2337/diabetes.45.12.1826

  5. Keymeulen, B

    • Long-term metabolic control by rat islet grafts depends on the composition of the implant. Diabetes December 1996 45:1814-1821; doi:10.2337/diabetes.45.12.1814

  6. Kiekens, R

    • Effects of chronically elevated glucose levels on the functional properties of rat pancreatic beta-cells. Diabetes December 1996 45:1774-1782; doi:10.2337/diabetes.45.12.1774

  7. Klip, A

    • Stimulation of glucose uptake by the natural coenzyme alpha-lipoic acid/thioctic acid: participation of elements of the insulin signaling pathway. Diabetes December 1996 45:1798-1804; doi:10.2337/diabetes.45.12.1798

  8. Kloppel, G

    • Effects of chronically elevated glucose levels on the functional properties of rat pancreatic beta-cells. Diabetes December 1996 45:1774-1782; doi:10.2337/diabetes.45.12.1774

  9. Klöppel, G

    • Long-term metabolic control by rat islet grafts depends on the composition of the implant. Diabetes December 1996 45:1814-1821; doi:10.2337/diabetes.45.12.1814

  10. Knip, M

    • Disease-associated antibodies in offspring of mothers with IDDM. Diabetes December 1996 45:1706-1710; doi:10.2337/diabetes.45.12.1706

  11. Kochakian, M

    • Chronic dosing with aminoguanidine and novel advanced glycosylation end product-formation inhibitors ameliorates cross-linking of tail tendon collagen in STZ-induced diabetic rats. Diabetes December 1996 45:1694-1700; doi:10.2337/diabetes.45.12.1694

  12. Komatsu, M

    • The betaHC-9 pancreatic beta-cell line preserves the characteristics of progenitor mouse islets. Diabetes December 1996 45:1766-1773; doi:10.2337/diabetes.45.12.1766

  13. Korbutt, G

    • Long-term metabolic control by rat islet grafts depends on the composition of the implant. Diabetes December 1996 45:1814-1821; doi:10.2337/diabetes.45.12.1814

  14. Kosaki, A

    • Reduced expression of the leptin gene (ob) by catecholamine through a G(S) protein-coupled pathway in 3T3-L1 adipocytes. Diabetes December 1996 45:1744-1749; doi:10.2337/diabetes.45.12.1744

  15. Koskela, P

    • Disease-associated antibodies in offspring of mothers with IDDM. Diabetes December 1996 45:1706-1710; doi:10.2337/diabetes.45.12.1706

  16. Kubota, A

    • Identification of two missense mutations in the GIP receptor gene: a functional study and association analysis with NIDDM: no evidence of association with Japanese NIDDM subjects. Diabetes December 1996 45:1701-1705; doi:10.2337/diabetes.45.12.1701

  17. Kulmala, P K

    • Disease-associated antibodies in offspring of mothers with IDDM. Diabetes December 1996 45:1706-1710; doi:10.2337/diabetes.45.12.1706

  18. Kuzuya, H

    • Reduced expression of the leptin gene (ob) by catecholamine through a G(S) protein-coupled pathway in 3T3-L1 adipocytes. Diabetes December 1996 45:1744-1749; doi:10.2337/diabetes.45.12.1744

L

  1. Lang, Y

    • Major histocompatibility complex class II molecules function as a template for the processing of a partially processed insulin peptide into a T-cell epitope. Diabetes December 1996 45:1711-1719; doi:10.2337/diabetes.45.12.1711

  2. Li, M

    • Abnormally expressed low-voltage-activated calcium channels in beta-cells from NOD mice and a related clonal cell line. Diabetes December 1996 45:1678-1683; doi:10.2337/diabetes.45.12.1678

  3. Ling, Z

    • Effects of chronically elevated glucose levels on the functional properties of rat pancreatic beta-cells. Diabetes December 1996 45:1774-1782; doi:10.2337/diabetes.45.12.1774

M

  1. Maffei, A

    • Tissue-specific self-peptides bound by major histocompatibility complex class I molecules of a human pancreatic beta-cell line. Diabetes December 1996 45:1761-1765; doi:10.2337/diabetes.45.12.1761

  2. Mahler, T

    • Effects of chronically elevated glucose levels on the functional properties of rat pancreatic beta-cells. Diabetes December 1996 45:1774-1782; doi:10.2337/diabetes.45.12.1774

  3. Malaisse, W J

    • Effects of chronically elevated glucose levels on the functional properties of rat pancreatic beta-cells. Diabetes December 1996 45:1774-1782; doi:10.2337/diabetes.45.12.1774

  4. Manjula, B N

    • Chronic dosing with aminoguanidine and novel advanced glycosylation end product-formation inhibitors ameliorates cross-linking of tail tendon collagen in STZ-induced diabetic rats. Diabetes December 1996 45:1694-1700; doi:10.2337/diabetes.45.12.1694

  5. Martikainen, A

    • Disease-associated antibodies in offspring of mothers with IDDM. Diabetes December 1996 45:1706-1710; doi:10.2337/diabetes.45.12.1706

  6. Martín, F

    • Diminished fraction of blockable ATP-sensitive K+ channels in islets transplanted into diabetic mice. Diabetes December 1996 45:1755-1760; doi:10.2337/diabetes.45.12.1755

  7. Matsuoka, T

    • PDX-1 induces insulin and glucokinase gene expressions in alphaTC1 clone 6 cells in the presence of betacellulin. Diabetes December 1996 45:1826-1831; doi:10.2337/diabetes.45.12.1826

  8. Matsuzawa, Y

    • PDX-1 induces insulin and glucokinase gene expressions in alphaTC1 clone 6 cells in the presence of betacellulin. Diabetes December 1996 45:1826-1831; doi:10.2337/diabetes.45.12.1826

  9. Meredith, M

    • Dual functional effects of interleukin-1beta on purine nucleotides and insulin secretion in rat islets and INS-1 cells. Diabetes December 1996 45:1783-1791; doi:10.2337/diabetes.45.12.1783

  10. Metz, S A

    • Dual functional effects of interleukin-1beta on purine nucleotides and insulin secretion in rat islets and INS-1 cells. Diabetes December 1996 45:1783-1791; doi:10.2337/diabetes.45.12.1783

  11. Miyagawa, J

    • PDX-1 induces insulin and glucokinase gene expressions in alphaTC1 clone 6 cells in the presence of betacellulin. Diabetes December 1996 45:1826-1831; doi:10.2337/diabetes.45.12.1826

  12. Montana, E

    • Diminished fraction of blockable ATP-sensitive K+ channels in islets transplanted into diabetic mice. Diabetes December 1996 45:1755-1760; doi:10.2337/diabetes.45.12.1755

  13. Mookhtiar, K A

    • Heterologous expression and characterization of rat liver glucokinase regulatory protein. Diabetes December 1996 45:1670-1677; doi:10.2337/diabetes.45.12.1670

  14. Munn, S R

    • Mechanisms of sulfonylurea's stimulation of insulin secretion in vivo: selective amplification of insulin secretory burst mass. Diabetes December 1996 45:1792-1797; doi:10.2337/diabetes.45.12.1792

  15. Myers, S R

    • In the absence of counterregulatory hormones, the increase in hepatic glucose production during insulin-induced hypoglycemia in the dog is initiated in the liver rather than the brain. Diabetes December 1996 45:1805-1813; doi:10.2337/diabetes.45.12.1805

N

  1. Nacher, V

    • Diminished fraction of blockable ATP-sensitive K+ channels in islets transplanted into diabetic mice. Diabetes December 1996 45:1755-1760; doi:10.2337/diabetes.45.12.1755

  2. Neal, D W

    • In the absence of counterregulatory hormones, the increase in hepatic glucose production during insulin-induced hypoglycemia in the dog is initiated in the liver rather than the brain. Diabetes December 1996 45:1805-1813; doi:10.2337/diabetes.45.12.1805

  3. Noda, M

    • The betaHC-9 pancreatic beta-cell line preserves the characteristics of progenitor mouse islets. Diabetes December 1996 45:1766-1773; doi:10.2337/diabetes.45.12.1766

O

  1. Olefsky, J M

    • Thiazolidinediones in the treatment of insulin resistance and type II diabetes. Diabetes December 1996 45:1661-1669; doi:10.2337/diabetes.45.12.1661

P

  1. Papadopoulos, K P

    • Tissue-specific self-peptides bound by major histocompatibility complex class I molecules of a human pancreatic beta-cell line. Diabetes December 1996 45:1761-1765; doi:10.2337/diabetes.45.12.1761

  2. Peshock, R M

    • Relationship of generalized and regional adiposity to insulin sensitivity in men with NIDDM. Diabetes December 1996 45:1684-1693; doi:10.2337/diabetes.45.12.1684

  3. Pipeleers, D G

    • Effects of chronically elevated glucose levels on the functional properties of rat pancreatic beta-cells. Diabetes December 1996 45:1774-1782; doi:10.2337/diabetes.45.12.1774
    • Long-term metabolic control by rat islet grafts depends on the composition of the implant. Diabetes December 1996 45:1814-1821; doi:10.2337/diabetes.45.12.1814

  4. Pipeleers-Marichal, M

    • Effects of chronically elevated glucose levels on the functional properties of rat pancreatic beta-cells. Diabetes December 1996 45:1774-1782; doi:10.2337/diabetes.45.12.1774

  5. Pørksen, N K

    • Mechanisms of sulfonylurea's stimulation of insulin secretion in vivo: selective amplification of insulin secretory burst mass. Diabetes December 1996 45:1792-1797; doi:10.2337/diabetes.45.12.1792

R

  1. Rabaglia, M E

    • Dual functional effects of interleukin-1beta on purine nucleotides and insulin secretion in rat islets and INS-1 cells. Diabetes December 1996 45:1783-1791; doi:10.2337/diabetes.45.12.1783

  2. Ramlal, T

    • Stimulation of glucose uptake by the natural coenzyme alpha-lipoic acid/thioctic acid: participation of elements of the insulin signaling pathway. Diabetes December 1996 45:1798-1804; doi:10.2337/diabetes.45.12.1798

  3. Reijonen, H

    • Disease-associated antibodies in offspring of mothers with IDDM. Diabetes December 1996 45:1706-1710; doi:10.2337/diabetes.45.12.1706

  4. Ren, J

    • Troglitazone attenuates high-glucose-induced abnormalities in relaxation and intracellular calcium in rat ventricular myocytes. Diabetes December 1996 45:1822-1825; doi:10.2337/diabetes.45.12.1822

  5. Robinson, G W

    • Heterologous expression and characterization of rat liver glucokinase regulatory protein. Diabetes December 1996 45:1670-1677; doi:10.2337/diabetes.45.12.1670

  6. Rossetti, L

    • Increased hexosamine availability similarly impairs the action of insulin and IGF-1 on glucose disposal. Diabetes December 1996 45:1734-1743; doi:10.2337/diabetes.45.12.1734

S

  1. Saltiel, A R

    • Thiazolidinediones in the treatment of insulin resistance and type II diabetes. Diabetes December 1996 45:1661-1669; doi:10.2337/diabetes.45.12.1661

  2. Sanchez-Andrés, J V

    • Diminished fraction of blockable ATP-sensitive K+ channels in islets transplanted into diabetic mice. Diabetes December 1996 45:1755-1760; doi:10.2337/diabetes.45.12.1755

  3. Saukkonen, T

    • Disease-associated antibodies in offspring of mothers with IDDM. Diabetes December 1996 45:1706-1710; doi:10.2337/diabetes.45.12.1706

  4. Schmitz, O

    • Mechanisms of sulfonylurea's stimulation of insulin secretion in vivo: selective amplification of insulin secretory burst mass. Diabetes December 1996 45:1792-1797; doi:10.2337/diabetes.45.12.1792

  5. Schuit, F C

    • Effects of chronically elevated glucose levels on the functional properties of rat pancreatic beta-cells. Diabetes December 1996 45:1774-1782; doi:10.2337/diabetes.45.12.1774

  6. Seino, Y

    • Identification of two missense mutations in the GIP receptor gene: a functional study and association analysis with NIDDM: no evidence of association with Japanese NIDDM subjects. Diabetes December 1996 45:1701-1705; doi:10.2337/diabetes.45.12.1701

  7. Sener, A

    • Effects of chronically elevated glucose levels on the functional properties of rat pancreatic beta-cells. Diabetes December 1996 45:1774-1782; doi:10.2337/diabetes.45.12.1774

  8. Sharp, G W

    • The betaHC-9 pancreatic beta-cell line preserves the characteristics of progenitor mouse islets. Diabetes December 1996 45:1766-1773; doi:10.2337/diabetes.45.12.1766

  9. Smith-Monroy, C

    • Heterologous expression and characterization of rat liver glucokinase regulatory protein. Diabetes December 1996 45:1670-1677; doi:10.2337/diabetes.45.12.1670

  10. Someya, Y

    • Identification of two missense mutations in the GIP receptor gene: a functional study and association analysis with NIDDM: no evidence of association with Japanese NIDDM subjects. Diabetes December 1996 45:1701-1705; doi:10.2337/diabetes.45.12.1701

  11. Soria, B

    • Diminished fraction of blockable ATP-sensitive K+ channels in islets transplanted into diabetic mice. Diabetes December 1996 45:1755-1760; doi:10.2337/diabetes.45.12.1755

  12. Sowers, J R

    • Troglitazone attenuates high-glucose-induced abnormalities in relaxation and intracellular calcium in rat ventricular myocytes. Diabetes December 1996 45:1822-1825; doi:10.2337/diabetes.45.12.1822

  13. Speck, E

    • Major histocompatibility complex class II molecules function as a template for the processing of a partially processed insulin peptide into a T-cell epitope. Diabetes December 1996 45:1711-1719; doi:10.2337/diabetes.45.12.1711

  14. Steers, J L

    • Mechanisms of sulfonylurea's stimulation of insulin secretion in vivo: selective amplification of insulin secretory burst mass. Diabetes December 1996 45:1792-1797; doi:10.2337/diabetes.45.12.1792

  15. Stray-Gundersen, J

    • Relationship of generalized and regional adiposity to insulin sensitivity in men with NIDDM. Diabetes December 1996 45:1684-1693; doi:10.2337/diabetes.45.12.1684

  16. Suciu-Foca, N

    • Tissue-specific self-peptides bound by major histocompatibility complex class I molecules of a human pancreatic beta-cell line. Diabetes December 1996 45:1761-1765; doi:10.2337/diabetes.45.12.1761

T

  1. Taminato, T

    • Identification of two missense mutations in the GIP receptor gene: a functional study and association analysis with NIDDM: no evidence of association with Japanese NIDDM subjects. Diabetes December 1996 45:1701-1705; doi:10.2337/diabetes.45.12.1701

  2. Teramo, K

    • Disease-associated antibodies in offspring of mothers with IDDM. Diabetes December 1996 45:1706-1710; doi:10.2337/diabetes.45.12.1706

  3. Tritschler, H

    • Stimulation of glucose uptake by the natural coenzyme alpha-lipoic acid/thioctic acid: participation of elements of the insulin signaling pathway. Diabetes December 1996 45:1798-1804; doi:10.2337/diabetes.45.12.1798

  4. Tsakiridis, T

    • Stimulation of glucose uptake by the natural coenzyme alpha-lipoic acid/thioctic acid: participation of elements of the insulin signaling pathway. Diabetes December 1996 45:1798-1804; doi:10.2337/diabetes.45.12.1798

  5. Tsay, Y H

    • Heterologous expression and characterization of rat liver glucokinase regulatory protein. Diabetes December 1996 45:1670-1677; doi:10.2337/diabetes.45.12.1670

  6. Tsuda, K

    • Identification of two missense mutations in the GIP receptor gene: a functional study and association analysis with NIDDM: no evidence of association with Japanese NIDDM subjects. Diabetes December 1996 45:1701-1705; doi:10.2337/diabetes.45.12.1701

V

  1. Veldhuis, J D

    • Mechanisms of sulfonylurea's stimulation of insulin secretion in vivo: selective amplification of insulin secretory burst mass. Diabetes December 1996 45:1792-1797; doi:10.2337/diabetes.45.12.1792

  2. Viberti, G

    • Glomerular hyperfiltration in the prediction of nephropathy in IDDM: a 10-year follow-up study. Diabetes December 1996 45:1729-1733; doi:10.2337/diabetes.45.12.1729

  3. Volchuk, A

    • Stimulation of glucose uptake by the natural coenzyme alpha-lipoic acid/thioctic acid: participation of elements of the insulin signaling pathway. Diabetes December 1996 45:1798-1804; doi:10.2337/diabetes.45.12.1798

W

  1. Wang, L

    • Abnormally expressed low-voltage-activated calcium channels in beta-cells from NOD mice and a related clonal cell line. Diabetes December 1996 45:1678-1683; doi:10.2337/diabetes.45.12.1678

  2. Watada, H

    • PDX-1 induces insulin and glucokinase gene expressions in alphaTC1 clone 6 cells in the presence of betacellulin. Diabetes December 1996 45:1826-1831; doi:10.2337/diabetes.45.12.1826

  3. Watanabe, R

    • Identification of two missense mutations in the GIP receptor gene: a functional study and association analysis with NIDDM: no evidence of association with Japanese NIDDM subjects. Diabetes December 1996 45:1701-1705; doi:10.2337/diabetes.45.12.1701

  4. Wiseman, M J

    • Glomerular hyperfiltration in the prediction of nephropathy in IDDM: a 10-year follow-up study. Diabetes December 1996 45:1729-1733; doi:10.2337/diabetes.45.12.1729

Y

  1. Yamada, K

    • Reduced expression of the leptin gene (ob) by catecholamine through a G(S) protein-coupled pathway in 3T3-L1 adipocytes. Diabetes December 1996 45:1744-1749; doi:10.2337/diabetes.45.12.1744

  2. Yamada, Y

    • Identification of two missense mutations in the GIP receptor gene: a functional study and association analysis with NIDDM: no evidence of association with Japanese NIDDM subjects. Diabetes December 1996 45:1701-1705; doi:10.2337/diabetes.45.12.1701

  3. Yamamoto, K

    • PDX-1 induces insulin and glucokinase gene expressions in alphaTC1 clone 6 cells in the presence of betacellulin. Diabetes December 1996 45:1826-1831; doi:10.2337/diabetes.45.12.1826

  4. Yamasaki, Y

    • PDX-1 induces insulin and glucokinase gene expressions in alphaTC1 clone 6 cells in the presence of betacellulin. Diabetes December 1996 45:1826-1831; doi:10.2337/diabetes.45.12.1826

  5. Yasuda, K

    • Identification of two missense mutations in the GIP receptor gene: a functional study and association analysis with NIDDM: no evidence of association with Japanese NIDDM subjects. Diabetes December 1996 45:1701-1705; doi:10.2337/diabetes.45.12.1701

  6. Yip, J W

    • Glomerular hyperfiltration in the prediction of nephropathy in IDDM: a 10-year follow-up study. Diabetes December 1996 45:1729-1733; doi:10.2337/diabetes.45.12.1729

Current Issue

  1. February 2012, 61 (2)
  1. Current Issue
  1. Alert me to new issues of Diabetes
Advertisement